Real-time enrollment status for this thyroid eye disease clinical trial
Current Status
Terminated
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT06307626 |
| Recruiting Status | Terminated |
| Condition | Thyroid Eye Disease |
| Phase | Clinical Trial |
| Target Enrollment | 123 participants |
| Active Locations | 11 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | March 16, 2026 (Mar 16, 2026) |
As of April 17, 2026: Clinical trial NCT06307626 is currently terminated participants. This clinical trial study for thyroid eye disease is not currently accepting new participants at 11 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06307626 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06307626 was last updated Mar 16, 2026 (March 16, 2026). HelloStudys verifies this status automatically.